Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
FDA Adds Heart Warning to Quetiapine's Label
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
FDA Adds Heart Warning to Quetiapine's Label
Admin Wed Jul 20, 2011 10:03 pm
FDA Adds Heart Warning to Quetiapine's Label
The FDA has added a warning to the label of the atypical antipsychotic quetiapine (Seroquel) cautioning about potential increases in the QT interval.
Postmarketing cases of QT prolongation have been reported in some 17 patients, according to the New York Times. These patients had overdosed on quetiapine, had other illnesses, or were taking other medications that can cause electrolyte imbalance or QT prolongation.
The new label warns against using quetiapine in conjunction with such drugs, including:
class 1A antiarrhythmics (e.g., quinidine, procainamide)
class III antiarrhythmics (e.g., amiodarone, sotalol)
antipsychotics (e.g., ziprasidone, chlorpromazine, thioridazine)
antibiotics (e.g., gatifloxacin, moxifloxacin)
other drugs associated with QT prolongation (e.g., pentamidine, methadone)
Read the article here --> New York Times
The FDA has added a warning to the label of the atypical antipsychotic quetiapine (Seroquel) cautioning about potential increases in the QT interval.
Postmarketing cases of QT prolongation have been reported in some 17 patients, according to the New York Times. These patients had overdosed on quetiapine, had other illnesses, or were taking other medications that can cause electrolyte imbalance or QT prolongation.
The new label warns against using quetiapine in conjunction with such drugs, including:
class 1A antiarrhythmics (e.g., quinidine, procainamide)
class III antiarrhythmics (e.g., amiodarone, sotalol)
antipsychotics (e.g., ziprasidone, chlorpromazine, thioridazine)
antibiotics (e.g., gatifloxacin, moxifloxacin)
other drugs associated with QT prolongation (e.g., pentamidine, methadone)
Read the article here --> New York Times
Admin- Admin
- Posts : 948
Points : 2102
Reputation : 0
Join date : 2011-02-19
Location : Philadelphia -
Similar topics» FDA Warning: Serious Allergic Reactions Reported With Saphris (Asenapine Maleate)
» FDA Approves Label Changes for Antimalarial Drug Mefloquine Hydrochloride: Risk of Serious Psychiatric & Neuro Side Effects
» FDA Warning: Counterfeit Adderall 30 mg Tablets
» Celexa (citalopram hydrobromide): Abnormal Heart Rhythms Associated With High Doses
» Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
» FDA Approves Label Changes for Antimalarial Drug Mefloquine Hydrochloride: Risk of Serious Psychiatric & Neuro Side Effects
» FDA Warning: Counterfeit Adderall 30 mg Tablets
» Celexa (citalopram hydrobromide): Abnormal Heart Rhythms Associated With High Doses
» Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
» L-Methylfolate: Who Will benefit
» Vitamins & Supplements in Clinical Practice.
» Imaging Biomarkers for Outcomes in Mild TBI
» Q.5 Clozapine Neutopenia
» Treating Disorders!
» Cortical Abnormalities in Adults & Adolescents with MDD
» Efficacy of Antipsychotics in Pediatric Acute Mania
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?